Medical Practice of Peter Ruane MB
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ruane, Peter J
PILLAR, NCT05374525: A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United States

Active, not recruiting
4
116
US
APRETUDE, Cabotegravir OLI
ViiV Healthcare
HIV Infections
09/24
09/24
NCT05869643: A Clinical Trial of STP0404 in Treatment-Naïve Adults With HIV-1 Infection

Recruiting
2
36
US
Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir), Placebo
ST Pharm Co., Ltd.
HIV-1-infection
10/24
11/24
VAMOS, NCT05383456: The Visceral Adiposity Measurement and Observation Study

Completed
N/A
196
US
Diagnostic Test, CT Scan, Fibroscan, Urine and Blood testing, HIV Anti-retroviral Background Therapy
Theratechnologies, Dacima Consulting, Medpace, Inc., Vanderbilt University Medical Center, Echosens
HIV, HIV-Infections, HIV-1-infection, HIV I Infection, HIV Lipodystrophy, HIV Infection Primary, HIV-Associated Lipodystrophy, HIV Disease Progression, Lipohypertrophy, Liver Diseases, NAFLD, NASH, Liver Fibrosis, Hepatic Fibrosis, Waist Circumference, BMI, Ectopic Fat, Liver Fat, Hepatic Steatosis
10/23
10/23
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Recruiting
N/A
600
US
No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment
Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research
HIV Infections, Multi-Antiviral Resistance
06/25
12/25

Download Options